Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial

2021 ◽  
Author(s):  
Ram Malladi ◽  
Ikhlaaq Ahmed ◽  
Graham McIlroy ◽  
Fiona L. Dignan ◽  
Rachel Protheroe ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Graft Versus Host Disease ◽  
Host Disease ◽  
Graft Versus Host ◽  
Steroid Refractory

scholarly journals Phase I Clinical Trial Evaluating Abatacept in Patients with Steroid-Refractory Chronic Graft Versus Host Disease

2017 ◽  
Vol 23 (3) ◽  
pp. S376
Author(s):  
Myrna R. Nahas ◽  
Robert J. Soiffer ◽  
Edwin P. Alyea ◽  
Jon E. Arnason ◽  
Robin Joyce ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Graft Versus Host Disease ◽  
Phase I Clinical Trial ◽  
Host Disease ◽  
Graft Versus Host ◽  
Steroid Refractory

scholarly journals Alemtuzumab as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study

2009 ◽  
Vol 15 (5) ◽  
pp. 639-642 ◽  
Author(s):  
Carmen Martínez ◽  
Carlos Solano ◽  
Christelle Ferrá ◽  
Antonia Sampol ◽  
David Valcárcel ◽  
...  
Keyword(s):  
Phase Ii ◽  
Graft Versus Host Disease ◽  
Phase Ii Study ◽  
Host Disease ◽  
Graft Versus Host ◽  
Steroid Refractory ◽  
Acute Graft

scholarly journals A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease

2005 ◽  
Vol 11 (6) ◽  
pp. 465-471 ◽  
Author(s):  
Paul A. Carpenter ◽  
James Lowder ◽  
Laura Johnston ◽  
Haydar Frangoul ◽  
Hanna Khoury ◽  
...  
Keyword(s):  
Phase Ii ◽  
Graft Versus Host Disease ◽  
Multicenter Study ◽  
Host Disease ◽  
Graft Versus Host ◽  
Steroid Refractory ◽  
Acute Graft
Sign in / Sign up

Export Citation Format

Share Document